Literature DB >> 7824000

Recent advances in radiation oncology.

A S Lichter1, T S Lawrence.   

Abstract

Radiotherapy remains an important component of the management of malignant disease. Especially when combined with cytotoxic chemotherapy, limited surgical excision, or both, irradiation has been shown to control disease in the primary site and regional nodes without the need for surgical extirpation as frequently as in past years. New developments in three-dimensional treatment planning and the precise delivery of high-dose radiation promise to increase the benefit of radiation treatment. Finally, molecular studies of the cell's response to radiation and the phenomena of DNA damage and repair are providing explanations for heretofore unexplained radiobiologic observations. Such research is laying the groundwork for targeted manipulation of the cell's response to radiation, which will be tested in the near future.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7824000     DOI: 10.1056/NEJM199502093320607

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  25 in total

1.  A randomized, controlled trial of varying radiation doses in the treatment of choroidal melanoma.

Authors:  E S Gragoudas
Journal:  Trans Am Ophthalmol Soc       Date:  1998

Review 2.  The diagnosis and treatment of soft tissue sarcomas of the limbs.

Authors:  Holger Bannasch; Steffen U Eisenhardt; Anca-Ligia Grosu; Jürgen Heinz; Arash Momeni; G Björn Stark
Journal:  Dtsch Arztebl Int       Date:  2011-01-21       Impact factor: 5.594

Review 3.  HER-2 and NF-kappaB as the targets for therapy-resistant breast cancer.

Authors:  Kazi M Ahmed; Ning Cao; Jian Jian Li
Journal:  Anticancer Res       Date:  2006 Nov-Dec       Impact factor: 2.480

4.  [The meta-analysis of clinical studies on chemotherapy alone compared to a combination of chemotherapy plus radiotherapy in the treatment of Hodgkin's disease].

Authors:  M Baumann; T Herrmann; H Thames
Journal:  Strahlenther Onkol       Date:  1998-10       Impact factor: 3.621

5.  Contrast media use in radiation oncology: a prospective, controlled educational intervention study with retrospective analysis of patient outcomes.

Authors:  Christopher A Barker; Robert W Mutter; Lauren Q Shapiro; Zhigang Zhang; Suzanne L Wolden; Joachim Yahalom
Journal:  J Am Coll Radiol       Date:  2010-12       Impact factor: 5.532

Review 6.  Assessing the risk of second malignancies after modern radiotherapy.

Authors:  Wayne D Newhauser; Marco Durante
Journal:  Nat Rev Cancer       Date:  2011-05-19       Impact factor: 60.716

7.  High-dose 3-dimensional conformal radiotherapy with concomitant vinorelbine plus carboplatin in patients with non-small cell lung cancer: A feasibility study.

Authors:  Qiang Lin; Jun Wang; Yue'e Liu; Huiling Su; Na Wang; Yuehua Huang; Chao-Xing Liu; Ping Zhang; Yannan Zhao; Kun Chen
Journal:  Oncol Lett       Date:  2011-05-16       Impact factor: 2.967

Review 8.  Charged particles in radiation oncology.

Authors:  Marco Durante; Jay S Loeffler
Journal:  Nat Rev Clin Oncol       Date:  2009-12-01       Impact factor: 66.675

9.  Synchronous radiochemotherapy in unfavorable brain tumors of children and young adults.

Authors:  C Urban; M Benesch; B Pakisch; H Lackner; R Kerbl; W Schwinger; R Oberbauer
Journal:  J Neurooncol       Date:  1998-08       Impact factor: 4.130

10.  Biodistribution of TAT or QLPVM coupled to receptor targeted liposomes for delivery of anticancer therapeutics to brain in vitro and in vivo.

Authors:  Sushant Lakkadwala; Bruna Dos Santos Rodrigues; Chengwen Sun; Jagdish Singh
Journal:  Nanomedicine       Date:  2019-10-25       Impact factor: 5.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.